Abstract
The regulatory role of dopamine, a monoamine neurotransmitter and/or a neurohormone in controlling the secretion of several anterior pituitary hormones, cardiovascular, and renal functions, has already been extensively used by clinicians for therapeutic purposes. In addition to these important functions of dopamine, some recent reports also indicate its novel role in regulating malignant cell proliferation and controlling immune functions in tumor-bearing animals. Therefore, in this article, we discuss all the relevant information correlating dopamine and malignant tumor growth in order to understand the host-tumor relationship at the level of a neurotransmitter and/or a neurohormone.
Similar content being viewed by others
References
Glavin, G. and Szabo, S. (1990). Dig. Dis. Sci. 35, 1153–1161.
Mezey, E., Eisenhofer, G., Hansson, S., Hunyady, B., and Hoffman, B. J. (1998). Neuroendocrinology 67, 336–348.
Ganong, W. F., Alper, R. H., and Steele, M. K. (1985). In: Catecholamines as hormone regulators. Ben-Jonathan, N., Bahrs, J. M., and Weiners, R. I. (eds.). Raven: New York.
Ben-Jonathan, N. (1985). Endocr. Rev. 5, 564–589.
Dasgupta, P. S. and Lahiri, T. (1987). Med. Sci. Res. 15, 1301–1302.
Basu, S., Dasgupta, P. S., Ray, M. R., and Lahiri, T. (1992). Biogenic Amines 8, 191–197.
Basu, S., Banerjee, S., Dasgupta, P. S., and Roy Chowdhury, J. (1992). Biogenic Amines 9, 177–181.
Basu, S., Dasgupta, P. S., Lahiri, T., and Roy Chowdhury, J. (1993). Life Sci. 53, 415–424.
Basu, S. and Dasgupta, P. S. (2000). J. Neuroimmunol. 102, 113–124.
Bieganowska, K., Czlonkowska, A., Bidzinski, A., Mierzewska, H., and Korlak, J. (1993). J. Neuroimmunol. 42, 33–37.
Bieganowska, K., Czlonkowska, A., and Korlak, J. (1996). Immunopharmacology 35, 149–154.
Basu, S., Dasgupta, P. S., and Roy Chowdhury, J. (1995). J. Neuroimmunol. 60, 1–8.
Berczi, I. and Nagy, Y. (1988). In: Hormone and immunity. Berczi, I. and Kovac, K. (eds.). MTP: Boston.
Bernton, E. W., Bryant, H. U., and Holaday, J. W. (1991). In: Psychoneuroimmunology. Ader, R., Felten, D. L., and Cohen, N. (eds.). Academic: New York.
Kelley, K. W. (1991). In: Psychoneuroimmunology. Ader, R., Felten, D. L., and Cohen, N. (eds.). Academic: New York.
Dasgupta, P. S. and Lahiri, T. (1986). Med. Sci. Res. 14, 112–113.
Quadri, S. K., Clark, J. L., and Meites, J. (1973). Proc. Soc. Exp. Biol. Med. 142, 22–26.
Quadri, S. K., Kledzik, G. S., and Meites, J. (1973). Proc. Soc. Exp. Biol. Med. 142, 759–761.
Meites, J. (1980). J. Neural. Transm. 48, 25–42.
ThyagaRajan, S., Meites, J., and Quadri, S. K. (1993). Proc. Soc. Exp. Biol. Med. 203, 236–242.
ThyagaRajan, S., Meites, J., and Quadri, S. K. (1995). Endocrinology 136, 1103–1110.
ThyagaRajan, S., Felten, S. Y., and Felten, D. L. (1998). Cancer Lett. 123, 177–183.
ThyagaRajan, S. and Quadri, S. K. (1999). Endocrine 10, 225–232.
Yasui, Y. and Potter, J. D. (1999). Cancer Causes Control 10, 431–437.
Purdie, D. M., Bain, C. J., Siskind, V., Russell, P., Hacker, N. F., Ward, B. G., Quinn, M. A., and Green, A. C. (1999). Br. J. Cancer 81, 559–563.
Horwitz, E. M., Hanlon, A. L., Pinover, W. H., and Hanks, G. E. (1999). Radiat. Oncol. Investig. 7, 249–259.
Cadranel, J., Naccache, J., Wislez, M., and Mayaud, C. (1999). Respiration 66, 289–309.
Lollini, P. L. and Forni, G. (1999). Immunol. Today 20, 347–350.
Dasgupta, P. S. and Lahiri, T. (1985). Indian J. Cancer Chemother. 7, 27–30.
Dasgupta, P. S. and Lahiri, T. (1987). J. Cancer Res. Clin. Oncol. 113, 363–368.
Basu, S., Dasgupta, P. S., Lahiri, T. (1987). Med. Sci. Res. 15, 1113, 1114.
Wick, M. M. (1978). J. Invest. Dermatol. 71, 163, 164.
Wick, M. M. (1979). Cancer. Treat. Rep. 63, 991–997.
Wick, M. M. (1979). J. Natl. Cancer Inst. 63, 1465–1467.
Wick, M. M. (1981). Cancer Treat. Rep. 65, 861–867.
Wick, M. M. (1982). Cancer Treat. Rep. 66, 1657–1659.
Wick, M. M. (1983). J. Invest. Dermatol. 80 (Suppl.), 61s-62s.
Johnson, D. E., Ochieng, J., and Evans, S. L. (1995). Anticancer Drugs 6, 471–474.
Lai, C. T. and Yu, P. H. (1997). Biochem. Pharmacol. 53, 363–372.
Lai, C. T. and Yu, P. H. (1997). Toxicol. Appl. Pharmacol. 142, 186–191.
Wick, M. M. (1980). Cancer Res. 40, 1414–1418.
Wick, M. M. and Mui, A. (1981). J. Natl. Cancer Inst. 66, 351–354.
FitzGerald, G. B. and Wick, M. M. (1987). J. Invest. Dermatol. 88, 66–70.
Dickerman, S., Clark, J., Dickerman, E., and Meites, J. (1972). Neuroendocrinology 9, 332–340.
Knoll, J., Dallo, J., and Yen, T. (1989). Life Sci. 45, 525–531.
Dickson, R. B. and Lippman, M. E. (1992). Semin. Oncol. 19, 286–298.
Souberbielle, B. and Dalgleish, A. G. (1994). In: The Psychoimmunology of cancer: mind and body in the fight for survival. Lewis, C. E., Sullivan, C. O., and Baraclough, J. (eds.). Oxford University Press: New York.
Pasqualini, C., Bojda, F., Gaudoux, F., Guibert, B., Leviel, V., Teissier, E., Rips, R., and Kerdelhue, B. (1988). Neuroendocrinology 48, 320–327.
Anderson, E., Ferguson, J. E., Morten, H., Shalet, S. M., Robinson, E. L., and Howell, A. (1993). Eur. J. Cancer 29A, 209–217.
Bontenbal, M., Foekens, J. A., Lamberts, S. W., de Jong, F. H., van Putten, W. L., Braun, H. J., Burghouts, J. T., van der Linden, G. H., and Klijn, J. G. (1998). Br. J. Cancer 77, 115–122.
Dasgupta, P. S. and Lahiri, T. (1990). Arch. Geschwulstforch. 60, 439–442.
Dasgupta, P. S. and Lahiri, T. (1991). Indian J. Exp. Biol. 29, 86–88.
Dasgupta, P. S. and Lahiri, T. (1992). Neoplasma 39, 163–165.
Matera, L. (1996). Neuroimmunomodulation 4, 171–180.
Chikanza, I. C. (1999). Ann. NY Acad. Sci. 876, 119–130.
Uomoto, M., Nishibori, M., Nakaya, N., Takeuchi, Y., Iwagaki, H., Tanaka, N., and Saeki, K. (1998). J. Neurochem. 70, 260–267.
Mortensen, P. B. (1989). J. Epidemiol. Community Health 43, 43–47.
Mortensen, P. B. (1994). Schizophr. Res. 12, 185–194.
Saku, M., Tokudome, S., Ikeda, M., Kono, S., Makimoto, K., Uchimura, H., Makai, A., and Yoshimura, T. (1995). Int. J. Epidemiol. 24, 366–372.
Laruelle, M. (1998). Q. J. Nucl. Med. 42, 211–221.
Gurkalo, V. K., and Zabezhinksi, M. A. (1983). Vopr. Onkol. 29, 37–40.
Gurkalo, V. K. and Zabezhinski, M. A. (1984). Neoplasma 31, 183–189.
Iishi, H., Baba, M., Tatsuta, H., Okuda, S., and Taniguchi, H. (1992). Br. J. Cancer 65, 351–354.
Iishi, H., Baba, M., Tatsuta, M., Okuda, S., and Taniguchi, H. (1991). Cancer Res. 51, 6150–6152.
Gerson, S. C. and Baldessarini, R. J. (1980). Life Sci. 27, 1435–1451.
Tutton, P. J. and Barkla, D. H. (1987). Anticancer Res. 7, 1–12.
Nishikawa, H., Yokotani, K., and Fujiwara, M. (1987). J. Pharmacol. Exp. Ther. 240, 966–971.
Gurkalo, V. K. and Volfson, N. I. (1982). Arch. Geschwulstforsch. 52, 259–265.
Tatsuta, M., Iishi, H., Yamamura, H., Baba, M., and Taniguchi, H. (1988). Br. J. Cancer 58, 619–620.
Albanes, D. (1987). Cancer Res. 47, 1987–1992.
Lahiri, T., Banerjee, S., Dasgupta, P. S., and Ray, M. R. (1990). Neoplasma 37, 387–393.
Wick, M. M. (1989). J. Invest. Dermatol. 92, 329S-331S.
Shibata, M. A., Hirose, M., Yamada, M. Y., Tatematsu, M., Uwagawa, S., and Ito, N. (1990). Carcinogenesis 11, 997–1000.
Wegner, I. C., Dawirs, R. R., Grond, C., and Teuchert-Noodt, G. (1997). Life Sci. 60, 2005–2011.
Basu, S. and Dasgupta, P. S. (1997). Dig. Dis. Sci. 42, 1260–1264.
Basu, S. and Dasgupta, P. S. (1999). Dig. Dis. Sci. 44, 916–921.
Tagliaferri, P., Katsaros, D., Clair, T., Ally, S., Tortora, G., Neckers, L., Rubalcava, B., Parandoosh, Z., Chang, Y. A., Revankar, G. R., Crabtree, G. W., Robins, R. K., and Chung-Cho, Y. S. (1988). Cancer Res. 48, 1642–1650.
Gamet, L., Murat, J. C., Remaury, A., Remesy, C., Valet, P., Paris, H., and Denis-Pouxviel, C. (1992). J. Cell. Physiol. 150, 501–509.
Sidhu, A. (1997). J. Recept. Signal Transduct. Res. 17, 777–784.
Ishibashi, M., Fujisawa, M., Furue, H., Maeda, Y., Fukayama, H., and Yamaji, T. (1994). Cancer Res. 54, 3442–3446.
Senogles, S. E. (1994). Endocrinology 134, 783–789.
Coronas, V., Feron, F., Hen, R., Sicard, F., Jourdan, F., and Moyse, E. (1997). J. Neurochem. 69, 1870–1881.
Furuya, K. N., Thottassaery, J. V., Schuetz, E. G., Sharif, M., and Schuetz, J. D. (1997). J. Biol. Chem. 272, 11,518–11,525.
Orlowski, S., Valente, D., Garrigos, M., and Ezan, E. (1998). Biochem. Biophys. Res. Commun. 244, 481–488.
Pilon, C., Levesque, D., Dimitriadou, V., Griffon, N., Martres, M. P., Schwartz, J. C., and Sokoloff, P. (1994). Eur. J. Pharmacol. 268, 129–139.
Luo, Y., Kokkonen, G. C., Wang, X., Neve, K. A., and Roth, G. S. (1998). J. Neurochem. 71, 980–990.